ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
-14.52%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(-22%)
Cap. Flow
-$7.79M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
92.65%
Holding
13
New
3
Increased
2
Reduced
6
Closed
–
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$3.17M |
| 2 |
Adicet Bio
ACET
|
$3.06M |
| 3 |
Immatics
IMTX
|
$2.32M |
| 4 |
Repare Therapeutics
RPTX
|
$1.07M |
| 5 |
Arvinas
ARVN
|
$612K |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$7.28M |
| 2 |
Merus
MRUS
|
$6.33M |
| 3 |
Kymera Therapeutics
KYMR
|
$1.79M |
| 4 |
SLN
Silence Therapeutics
SLN
|
$1.41M |
| 5 |
Sutro Biopharma
STRO
|
$1.18M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arrowhead Research
ARWR
$3.05B
| $23.6M | 22.76% |
908,474
| – | – |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $12.4M | 11.91% |
114,600
-67,551
| -37% | -$7.28M |
|
|
3
Arvinas
ARVN
$568M
| $11.4M | 11% |
428,766
+23,000
| +6% | +$612K |
|
4
Regenxbio
RGNX
$451M
| $10.6M | 10.22% |
906,248
| – | – |
|
|
5
Kymera Therapeutics
KYMR
$2.95B
| $9.81M | 9.46% |
328,743
-60,000
| -15% | -$1.79M |
|
|
SLN
6
Silence Therapeutics
SLN
$227M
| $9.5M | 9.16% |
500,214
-74,000
| -13% | -$1.41M |
|
|
7
Merus
MRUS
$4.98B
| $8.76M | 8.45% |
148,109
-107,000
| -42% | -$6.33M |
|
8
Precision BioSciences
DTIL
$57.8M
| $3.71M | 3.58% |
381,803
-3,637
| -0.9% | -$35.4K |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$511M
| $3.17M | 3.06% |
+156,692
| New | +$3.17M |
|
|
10
Repare Therapeutics
RPTX
$71.7M
| $3.16M | 3.04% |
956,932
+323,661
| +51% | +$1.07M |
|
|
11
Adicet Bio
ACET
$59.9M
| $3.06M | 2.95% |
+2,531,194
| New | +$3.06M |
|
|
12
Immatics
IMTX
$619M
| $2.32M | 2.24% |
+200,000
| New | +$2.32M |
|
|
13
Sutro Biopharma
STRO
$72.7M
| $2.23M | 2.15% |
762,498
-402,968
| -35% | -$1.18M |
|